This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,526.20 firm fixed-price delivery order is for the supply of 200 mg/100 mL vials of the medication ropivacaine 0.2%. The contract has an ultimate completion date of October 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is part of that larger IDC. The contract award did not have a set-aside designation, indicating open competition. AmerisourceBergen's extensive experience in federal healthcare contracting, including with the DLA and Department of Justice, enables it to efficiently deliver critical medical commodities to serve the needs of military personnel, veterans, and other federal beneficiaries.
Generated 1/22/25, 9:22 AM